Headquarters Delaware, OH
Stage Series B
Company Size 11-50 Employees

Solace Lifesciences, Inc, introduces NuCalm®, a pioneering neuroscience technology globally acclaimed for its efficacy in stress reduction and sleep enhancement without resorting to pharmaceutical interventions. Leveraging over three decades of research and development, NuCalm guides brain wave frequencies to facilitate deliberate mental shifts, offering a seamless experience in stress alleviation and sleep improvement. Originally developed as a $6,000 FDA medical device, NuCalm has evolved into a consumer app, making its scientifically proven stress solution accessible to a wider audience.